Company: LGN
Filing Date: 2025-05-14
Form Type: DRS/A
Source: 0000950123-25-005247
Chunk: 113

Company: Legence Corp.
Filing Date: 2025-05-14
Form: DRS/A
Chunk 113
---
     | Year Ended        
 December 31, 2024 |
|:----------------------------------------------------------------------|:----|:------------------|
| Numerator:                                                            |     |                   |
| Net loss                                                              |     | $                 |
| Net income attributable to noncontrolling interests                   |     |                   |
| Net loss attributable to Legence Corp.                                |     |                   |
| Denominator:                                                          |     |                   |
| Weighted average shares of Class A Common Stock outstanding (basic)   |     |                   |
| Incremental common shares attributable to dilutive instruments(1)     |     |                   |
| Assumed conversion of LGN Units to shares of Class A Common Stock(2)  |     |                   |
| Weighted average shares of Class A Common Stock outstanding (diluted) |     |                   |
| Basic loss per share                                                  |     | $                 |
| Diluted loss per share                                                |     | $                 |

75

Confidential Treatment Requested by Legence Corp.

Pursuant to 17 C.F.R. Section 200.83

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and related notes that appear elsewhere in this prospectus. In addition to historical consolidated financial information, the following discussion contains “forward-looking statements” that reflect our future plans, estimates, beliefs and expected performance. The forward-looking statements are subject to numerous risks and uncertainties, including, but not limited to, the risks and uncertainties described under “Cautionary Statement Regarding Forward-Looking Statements” and “Risk Factors” and elsewhere in this prospectus. Our actual results may differ materially from those contained in or implied by any forward-looking statements. We do not undertake any obligation to publicly update any forward-looking statements except as otherwise required by applicable law. Unless otherwise indicated, the historical financial information presented in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” speaks only with respect to our predecessor, Legence Holdings and does not give pro forma effect to the Corporate Reorganization.

Overview

We are a leading provider of
engineering, installation and maintenance services for mission-critical systems in buildings. We focus on high-growth sectors that have technically demanding buildings, including technology, life sciences, healthcare and education. We count more
than 60% of the companies in the Nasdaq-100 Index as clients.

Our business is